Skip to main content
HNFHC logo

HNFHC — Investor Relations & Filings

Ticker · 2880 ISIN · TW0002880002 TW Financial and insurance activities
Filings indexed 3,005 across all filing types
Latest filing 2024-03-20 Annual Report
Country TW Taiwan
Listing TW 2880

About HNFHC

www.hnfhc.com.tw

Hua Nan Financial Holdings Co., Ltd. (HNFHC) is a diversified financial services group providing a comprehensive suite of banking and investment solutions. The organization operates through several specialized subsidiaries, with its banking division serving as the primary driver of revenue and operational focus. Core business activities include commercial banking, offshore banking, and international branch operations, complemented by a robust presence in securities brokerage, futures trading, and asset management. The group also maintains significant operations in property and casualty insurance, investment trusts, and venture capital. HNFHC focuses on delivering integrated financial products to a diverse clientele, including retail, corporate, and institutional investors. By leveraging a multi-channel distribution network and a broad portfolio of financial instruments, the company provides synergistic value and comprehensive wealth management services across multiple markets.

Recent filings

Filing Released Lang Actions
113年03月法人說明會簡報 — 288020240320E001.pdf
Annual Report Classification · 95% confidence The document is titled 'HNFHC 4Q 2023 Analyst Meeting' and contains detailed financial data for the full fiscal year 2023, including net profit, EPS, ROE, asset quality, capital structure, and subsidiary operating results. It includes comprehensive financial statements and analysis for the year ending 2023, with audited figures based on IFRS. The content is extensive (15,000 characters) and includes detailed financial performance and business highlights, which is characteristic of a full annual report. There is no indication that this is merely an announcement or a presentation; rather, it contains substantive financial data and analysis for the full fiscal year. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-03-20 Chinese
113年03月法人說明會簡報 — 288020240320M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a 2023 Q4 institutional investor presentation by Hua Nan Financial Holdings. It contains detailed financial performance data for the full year 2023 and the fourth quarter, including net profit, EPS, ROE, asset quality, capital structure, and business segment performance. It also includes strategic focus for 2024 and sustainability development. The content is comprehensive, with financial tables and charts, and is clearly aimed at investors to provide a detailed overview of financial results, business trends, and outlook. It is not a brief earnings release, nor a regulatory filing or announcement. It is not a full annual report (10-K) but rather a quarterly or interim report with substantive financial data and analysis. Therefore, the best classification is Interim / Quarterly Report (IR). FY 2023
2024-03-20 Chinese
113年03月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled corporate presentation event, specifically a '法人說明會' which translates to 'investor or analyst presentation' or 'investor conference call'. It includes the date, time, location, and links to presentation materials and webcast. The content is not a full financial report, earnings release, or regulatory filing but rather an announcement and summary of an investor presentation event. Therefore, it fits best under the category 'Investor Presentation (IP)'. The document length is short and it provides direct links to presentation files and webcast, consistent with an investor presentation notice rather than a full report or announcement of report publication.
2024-03-20 Chinese
代子公司華南金創投公告董事會通過投資TaiAx Life Science Fund L.P.
Capital/Financing Update Classification · 95% confidence The document is a disclosure from a listed company (華南金) about its subsidiary's board approval of an investment in TaiAx Life Science Fund L.P. It details the transaction amount, nature of the investment, decision-making process, and related party status. The document is short (1964 characters) and primarily announces a specific transaction approved by the board. It does not contain financial statements, comprehensive financial analysis, or detailed report content. It is a regulatory announcement about a capital investment decision, fitting the category of Capital/Financing Update (CAP).
2024-03-19 Chinese
112年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table showing key financial ratios and metrics for the company 華南金 over three fiscal years (110年度, 111年度, 112年度). The data includes financial structure, debt ratios, turnover rates, profitability ratios, and earnings per share. The document is relatively short (943 characters) and appears to be a summary or analysis of recent financial data rather than a full financial report. There is no indication that this is a full Annual Report (10-K) or Interim Report (IR), nor is it an announcement or certification. It resembles a brief financial factsheet or summary of key financial data. Given the concise nature and focus on key financial metrics over multiple years, the best fitting category is Fund Information / Factsheet (FS).
2024-03-14 Chinese
112年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment methods, cumulative investment amounts, and recognized investment gains. The document is relatively short (1681 characters) and does not appear to be a full financial report like an Annual Report or Interim Report. It is a regulatory disclosure of investment information, likely required by a regulatory body for transparency purposes. There is no indication that this is an announcement of a report publication or a certification. The content fits best under Regulatory Filings (RNS) as it is a compliance disclosure that does not fit other specific categories like Annual Report or Capital Update.
2024-03-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.